S10 Ep45: Bui and Kelly Discuss the Utility of Nab-Sirolimus in Advanced Malignant PEComa

from OncLive® On Air · host OncLive® On Air

Drs Bui and Kelly discuss key long-term findings from the AMPECT trial investigating nab-sirolimus in patients with advanced malignant PEComa.

Episode metadata supplied by the publisher feed · Published Jul 18, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

S10 Ep45: Bui and Kelly Discuss the Utility of Nab-Sirolimus in Advanced Malignant PEComa

0:00 17:30

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 17 minutes long.

This episode was published on July 18, 2024.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!